Literature DB >> 5533173

[Chronic insulin resistance].

J B Field.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5533173     DOI: 10.1007/bf01556784

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


× No keyword cloud information.
  61 in total

1.  RELATIONSHIP BETWEEN DIFFERENTIAL ANTIBODY BINDING CAPACITY AND CLINICAL REQUIREMENTS OF BEEF AND PORT INSULIN.

Authors:  J G DEVLIN; T G BRIEN
Journal:  Metabolism       Date:  1965-09       Impact factor: 8.694

2.  Tolbutamide in the therapy of insulin resistance.

Authors:  J C BARRETT; B R BOSHELL
Journal:  Diabetes       Date:  1962       Impact factor: 9.461

3.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

4.  Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects.

Authors:  C L JOINER
Journal:  Lancet       Date:  1959-05-09       Impact factor: 79.321

5.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

6.  Evidence for the insulin-directed specificity of rabbit anti-insulin serum.

Authors:  E R ARQUILLA; A B STAVITSKY
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

7.  Use of tolbutamide in insulin-resistant diabetes; report of a case.

Authors:  E O FRIEDLANDER
Journal:  N Engl J Med       Date:  1957-07-04       Impact factor: 91.245

8.  Sulphated insulin in resistant juvenile diabetes.

Authors:  A Goldschmied; L Laurian
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

9.  Sulfated insulin in mild, moderate, severe and insulin-resistant diabetes mellitus.

Authors:  J A Little; J H Arnott
Journal:  Diabetes       Date:  1966-07       Impact factor: 9.461

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.